The 67 rating InvestorsObserver gives to Cellectar Biosciences Inc (CLRB) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 81 percent of stocks in the Biotechnology industry, CLRB’s 67 overall rating means the stock scores better than 67 percent of all stocks.
CLRB has an Overall Score of 67. Find out what this means to you and get the rest of the rankings on CLRB!
Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.
What's Happening With Cellectar Biosciences Inc Stock Today?
Cellectar Biosciences Inc (CLRB) stock has gained 2.66% while the S&P 500 is down -0.68% as of 12:07 PM on Friday, Mar 15. CLRB has gained $0.09 from the previous closing price of $3.38 on volume of 179,185 shares. Over the past year the S&P 500 is up 29.17% while CLRB has gained 121.02%. CLRB lost -$3.44 per share the over the last 12 months.
Click Here to get the full Stock Report for Cellectar Biosciences Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
